Magnetic resonance imaging features of pubic symphysis urinary fistula with pubic bone osteomyelitis in the treated prostate cancer patient.

Introduction: Pubic bone osteomyelitis with pubic symphysis urinary fistula represents a debilitating complication of radiation and ablative treatments for prostate cancer. The definitive radiographic diagnosis of this clinical entity is not described. In this study, we characterize the plain film and magnetic resonance imaging findings of pubic osteomyelitis.

Pubic Bone Resection Provides Objective Pain Control in the Prostate Cancer Survivor With Pubic Bone Osteomyelitis With an Associated Urinary Tract to Pubic Symphysis Fistula.

Objective: To investigate pain intensity perception in prostate cancer survivors with pubic bone osteomyelitis with an associated urinary tract to pubic symphysis fistula before and after definitive surgical management.

Materials And Methods: We performed a review of an institutional review board-approved database of prostate cancer survivors with pubic bone osteomyelitis from 2010 to 2015. Demographic and clinical data were extracted.

Genitourinary Prosthetics: A Primer for the Non-urologic Surgeon.

Genitourinary prosthetics are used for correction of functional deficits and to improve the quality of lives of affected patients. General surgeons must evaluate patients scheduled for nonurologic surgery with urologic devices that can impact their perioperative management. Lack of recognition of these prosthetics preoperatively can lead to unnecessary morbidity for the patient and have legal implications for the surgeon.

Role of Ultrasonography for Testicular Injuries in Penetrating Scrotal Trauma.

Objective: To review our 12-year experience with penetrating scrotal trauma in civilians and to evaluate the diagnostic utility of scrotal ultrasound prior to operative intervention.

Materials And Methods: We retrospectively studied all patients who had sustained penetrating scrotal trauma between 2002 and 2014. Charts were reviewed for demographic data, mechanism of injury, scrotal ultrasound findings, patient treatment, and outcomes.

Management of the Recurrent Male Urethral Stricture.

Urethral stricture disease negatively impacts quality of life and leads to significant urologic pathology including lower urinary tract symptoms, recurrent urinary tract infections, and potentially more severe sequelae such as detrusor dysfunction, renal failure, urethral carcinoma, and Fournier's gangrene. Open urethral reconstruction is considered a durable and definitive treatment for urethral stricture with lifetime success rates ranging from 75-100%; however, strictures do recur up to 10 years after surgery. Recurrence rates vary by repair type.

Presentation of a Clitoral Mass in a Prepubescent Female: A Case Report and Discussion of the Evaluation.

Clitoral masses are rare. We present a case report of a prepubescent female with a periclitoral mass.

Impact of pelvic osteotomy on the incidence of inguinal hernias in classic bladder exstrophy.

Background/purpose: The high prevalence of inguinal hernias in the bladder exstrophy population is well documented. The authors' aim is to determine whether pelvic osteotomy reduces the incidence of primary and recurrent inguinal hernias in patients with classic bladder exstrophy.

Methods: Using an institutionally-approved database, patients who underwent immediate or delayed primary bladder closure between 1974 and 2012 were identified and stratified by the use of pelvic osteotomy at the time of closure.

Elimination of preoperative mechanical bowel preparation in patients undergoing cystectomy and urinary diversion.

Introduction: The utility of a preoperative mechanical bowel preparation prior to bowel surgery has recently been questioned. The purpose of this study is to compare the perioperative outcomes between patients undergoing cystectomy with urinary diversion with or without preoperative mechanical bowel preparation.

Methods: Seventy patients underwent radical cystectomy and urinary diversion between May 2008 and August 2009 for bladder cancer.